Filing Details
- Accession Number:
- 0000899243-23-018762
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-12 18:20:24
- Reporting Period:
- 2023-09-08
- Accepted Time:
- 2023-09-12 18:20:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1113148 | Infinity Pharmaceuticals Inc. | INFI | Pharmaceutical Preparations (2834) | 330655706 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1375124 | Q Adelene Perkins | C/O Infinity Pharmaceuticals, Inc. 1100 Massachusetts Avenue, Floor 4 Cambridge MA 02138 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-09-09 | 768,133 | $0.00 | 1,585,487 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-09-12 | 410,196 | $0.07 | 1,175,291 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Disposition | 2023-09-09 | 768,133 | $0.00 | 768,133 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 16,447 | Indirect | 401(K) |
Footnotes
- Restricted stock units ("RSUs") convert into Common Stock of the issuer on a one-for-one basis. This transaction represents the settlement of RSUs in shares of Common Stock on their vesting date.
- Pursuant to a binding contract entered into between the issuer and the reporting person on August 15, 2022, this represents the shares automatically sold by the reporting person to satisfy tax withholding obligations in connection with the vesting of the RSUs listed in Table II. Such binding contract is intended to be consistent with the affirmative action defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. This sale does not represent a discretionary trade by the reporting person.
- On August 11, 2022, the reporting person was granted RSUs, of which all 768,133 vested as of September 9, 2023.
Billionaire Hedge Funds
